© 2009 Enzo Life Sciences, Inc.
Enzo Biochem, Inc. is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and providing reference laboratory services to the medical community. Founded in 1976, the company has concentrated on the development of enabling technologies in the areas of gene regulation and gene modifi cation. Today, Enzo® technologies and products are recognized as the key tools in nonradioactive gene labeling used by researchers worldwide. The business activities of Enzo Biochem, Inc. are performed by the company‘s three wholly owned subsidiaries; Enzo Life Sciences, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc.
Enzo Life Sciences, Inc.
Enzo Life Sciences, Inc. is a subsidiary of Enzo Biochem, Inc. organized to lead in the development, production, marketing, and sales of innovative life science research reagents worldwide based on over 30 years of successful experience in building strong international market recognition, implementing outstanding operational capabilities, and establishing a state-of-the-art electronic information and ordering marketplace.
Enzo Life Sciences, Inc. is a recognized leader in labeling and detection technologies across research and diagnostic markets. A strong portfolio of labeling probes and dyes provides life science environments tools for target identification/validation and high content analysis via gene expression analysis, nucleic acid detection, protein biochemistry and detection, molecular biology, and cellular analysis.
Now incorporating the skills, experience and products of ALEXIS® Biochemicals, acquired in 2007, and BIOMOL® International, acquired in 2008, the Enzo® Life Sciences brand now provides 25 years of business experience in the supply of research biochemicals and biologicals “Enabling Discovery in Life Science™”.
Recent acquisitions
Founded in 1992 in Athens, Georgia and currently located in Ann Arbor, Michigan, Assay Designs® began as a small company with the goal of providing high quality, easy-to-use assay kits and highly characterized reagents to the life sciences research market. The portfolio of kits has grown from the first PGE2 EIA kit to the present offering of over 200 assays for biomarkers relevant to inflammation and immunity, oxidative and cellular stress, steroid and hormone biology, cell signaling, and metabolism. The Assay Designs acquisition of Stressgen Bioreagents in 2005 incorporated the definitive collection of Stressgen® brand antibodies, proteins, and kits for heat shock proteins, chaperones, and mediators of cellular stress to complement its product portfolio. Assay Designs continues to expand its presence in the life science research market with the continual release of innovative kits and reagents to serve these core research areas, also offering custom fit-for-purpose assay development services to clients on a contract basis.
Biomol International LP was formed by the merger of two leading companies in cellular biochemistry in 2004. Biomol Research Laboratories Inc., based in Plymouth Meeting, Pennsylvania, USA, was founded in 1983 focusing on the supply of innovative signal transduction reagents to the life science research market, while Affiniti Research Products Ltd., based in Exeter, UK, was founded in 1991 as a supplier of products and services to the neuroscience sector of the life science research market. The brand BIOMOL® International has continued to serve the cellular biochemistry sector of the life science research market with innovative research products and services launching hundreds of new products every year.
ALEXIS Corporation was founded in 1993/1994 in Switzerland and the USA by a team of experts in the field of life science research reagents. Over the past years the company has built fast growing and comprehensive product lines to serve the life science research market. Starting as an in-licensing, OEM and trading business, ALEXIS Corporation developed and acquired its own in-house manufacturing capabilities. By leveraging its own production with a series of proprietary product licensing arrangements with universities, research institutes, as well as biotech and biopharmaceutical companies, the brand ALEXIS® Biochemicals has developed a strong reputation among researchers for providing the most innovative products within its chosen market segments.
In April 2005 ALEXIS® Biochemicals was enhanced by the merger with the Swiss company Apotech Corporation, a life science reagents company, discovering, developing and producing new products in the field of immunology, apoptosis, and inflammation.
Business Structure
Today, Enzo® Life Sciences offers over 8,000 products to the research community using a variety of marketing and sales channels. To serve our customers worldwide, we support the sales and distribution of our products directly through our global companies and through a network of over 50 partner companies.
